article thumbnail

8 Creative Pricing Strategies Most Startups Overlook

Startup Professionals Musings

As an advisor to new business owners, I’m accustomed to seeing primarily the simple traditional product pricing strategies , usually driven by competitor prices, or cost plus a reasonable margin. I often wonder whether you as the entrepreneur have worked as hard on your pricing strategy as you have on your innovative solution.

Pricing 145
article thumbnail

20 Best Free and Paid Tools for Startups in 2023

Tech.Co

But while competition remains fierce, the advancement and accessibility of smart solutions are making it easy than ever for startups to find their feet. Lenido Startup tool: Accounting software Price: Free Accounting software doesn't need to come at a premium. VPN Startup tool: VPN Price: Free Hide.me

Tool 128
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More

Xconomy

Two imminent FDA rulings on two separate drugs aren’t just noteworthy for the patients they’ll help, but the long and winding road their developers have taken to get to this point. First is Alnylam Pharmaceuticals, which has spent 16 years and over $2 billion to try to bring an unproven form of medicine, RNA interference (RNAi), to market.

News 57
article thumbnail

More Drama on the Cloud Price Wars Front

Tech Zulu Event

Perhaps it should come as no surprise that the cloud price wars have flared up once again. After taking a brief hiatus amidst nervous tensions, competition between cloud computing vendors has reached a fever pitch in the past month. The cloud price wars (sometimes known as the “Race to Zero”) aren’t exactly a new phenomenon.

Pricing 40
article thumbnail

9 Innovative Startups To Watch For in 2024

Tech.Co

Verifying Looking for regular tech news straight to your inbox? Source: hibobbie.com The company also raised an impressive $70 million in funding in June to acquire the legacy pediatric nutrition brand Nature’s One, bringing its total kitty up to $142 million and helping to secure its competitive advantage in the industry going forward.

Startup 210
article thumbnail

Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More

Xconomy

In the meantime, however, the news hasn’t been all bad for drugmakers. And new treatments to expand the reach of cystic fibrosis therapies have begun clinical testing. The news came with some caveats, however, as TheStreet.com explains here. THIS WEEK IN DRUG PRICING…. AND IN OTHER NEWS…. difficile infection.

Pricing 40
article thumbnail

Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More

Xconomy

With President Trump holed up in New Jersey, rattling his saber at Kim Jong-un and Mitch McConnell and ignoring his own commission’s advice on the opioid crisis, there was still life sciences news from the nation’s capital.

Pricing 52